Osaka, Japan

Shuichi Ohuchida


 

Average Co-Inventor Count = 2.8

ph-index = 12

Forward Citations = 401(Granted Patents)


Location History:

  • Nishinomiya, JP (1980)
  • Kyoto, JP (1979 - 2002)
  • Mishima-gun, JP (2000 - 2003)
  • Osaka, JP (1991 - 2009)

Company Filing History:


Years Active: 1979-2009

Loading Chart...
Loading Chart...
Areas of Expertise:
Pentanoic Acid Derivatives
Prostaglandin Derivatives
Sulfonamide Derivatives
Carboxamide Derivatives
Heterocyclic Compounds
Benzopyran Derivatives
Prolinal Derivatives
Thiazolidine Derivatives
Fused Phenol Derivatives
Pharmaceutical Compositions
Prostaglandin Analogues
Amnesia Treatment
43 patents (USPTO):Explore Patents

Title: Shuichi Ohuchida: Innovator in Neurodegenerative Disease Treatment

Introduction:

Shuichi Ohuchida, based in Osaka, Japan, is an accomplished inventor and researcher working in the field of pharmaceuticals. He has made significant contributions in the development of treatments for neurodegenerative diseases, specifically Alzheimer's and neuronal dysfunction caused by stroke or traumatic injury such as Multiple Sclerosis. With 43 patents to his name, Shuichi Ohuchida has established himself as a prominent figure in the field of medicinal chemistry.

Latest Patents:

Among Shuichi Ohuchida's notable recent patents are Pentanoic acid derivatives, specifically compounds represented by Formula (I) and (X). These compounds, when formulated as non-toxic and acid addition salts, have shown potential in preventing and/or treating neurodegenerative diseases. The compounds described in the patents exhibit various substituents, such as fluorine, hydroxy, alkoxy, phenyl, alkyl, heterocyclic rings, and amino acid residues, contributing to their therapeutic properties.

Career Highlights:

Shuichi Ohuchida has dedicated his career to the research and development of innovative pharmaceutical products. He is currently associated with Ono Pharmaceutical Co., Ltd., a renowned pharmaceutical company known for its advancements in drug discovery and development. Ono Pharmaceuticals Co., Ltd. is respected globally for its contributions to healthcare, and Shuichi Ohuchida plays an integral role within the organization.

Collaborations:

Within the research and pharmaceutical community, collaboration is crucial for advancing innovation. Shuichi Ohuchida has collaborated with distinguished individuals in his field, including Masaaki Toda and Hiroyuki Ohno, both of whom are respected researchers and colleagues. These collaborations have fueled knowledge sharing and the development of groundbreaking treatments for neurodegenerative diseases.

Conclusion:

Shuichi Ohuchida's trailblazing contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases, have been recognized through his numerous patents and collaborations. His expertise and dedication in medicinal chemistry have propelled advancements in neurology and brought hope to those suffering from conditions such as Alzheimer's and neuronal dysfunction due to stroke or traumatic injury. Shuichi Ohuchida continues to inspire and contribute to the ever-evolving landscape of pharmaceutical innovations aimed at improving patient lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…